چکیده مقاله
Novel coronavirus disease COVID 19 has attracted much attention around the world due to its rapid transmission among humans and relatively high mortality rate Studies are increasing to find the best therapeutic approach for the disease and its management Regenerative medicine offers various cell tissue therapeutics and related products, such as stem cell therapy, natural killer NK cell therapy, Chimeric antigen receptor CAR T cell therapy, exosomes, and tissue products Interestingly, mesenchymal stem cells MSCs can reduce inflammatory symptoms and protect against cytokine storm, which critically contributes to the COVID 19 progression Notably, having the potentials to exert cytotoxic effects on infected cells and induce interferon production probably make NK cells a candidate for COVID 19 cell therapy Besides, exosomes are one of the crucial products of cells that can exert therapeutic effects through the induction of immune responses and neutralizing antibody titers The paper aims to briefly consider current options for COVID 19 therapy to show that there is no specific cure for COVID 19, and then assess the real opportunities and range of promises regenerative medicine can provide for specific treatment of COVID 19
نویسندگان
Nadia Ghasemi Darestani
Soheyla HashemiZahra RahimiRaheleh Janghorbanian poodeh
Soheyla Hashemi
Nadia Ghasemi DarestaniZahra RahimiRaheleh Janghorbanian poodeh
Zahra Rahimi
Nadia Ghasemi DarestaniSoheyla HashemiRaheleh Janghorbanian poodeh
Raheleh Janghorbanian poodeh
Nadia Ghasemi DarestaniSoheyla HashemiZahra Rahimi
شیوه ارجاع
Ghasemi Darestani, Nadia and Hashemi, Soheyla and Rahimi, Zahra and Janghorbanian poodeh, Raheleh,1402,Stem cell and Regenerative Medicine in relation with Covid -19 virus review,The 12th international conference on new findings in obstetrics, women, childbirth and infertility
ارائهشده در
مجموعه مقالات دوازدهمین کنفرانس بین المللی یافته های نو در مامایی، زنان، زایمان و نازایی18 اسفند 1402